Intratumor Heterogeneity in Early Lung Adenocarcinoma
- PMID: 32257951
- PMCID: PMC7090158
- DOI: 10.3389/fonc.2020.00349
Intratumor Heterogeneity in Early Lung Adenocarcinoma
Abstract
Lung cancer is one of the deadliest diseases in the world and is the leading cause of cancer-related deaths. Among the histological types, adenocarcinoma is the most common, and it is characterized by a high degree of heterogeneity at many levels including clinical, behavioral, cellular and molecular. While most lung cancers are known for their aggressive behavior, up to 18.5% of lung cancers detected by CT screening are indolent and put patients at risk for overdiagnosis and overtreatment. The cellular and molecular underpinnings of tumor behavior remain largely unknown. In the recent years, the study of intratumor heterogeneity has become an attractive strategy to understand tumor progression. This review will summarize some of the current known determinants of lung adenocarcinoma behavior and discuss recent efforts to dissect its intratumor heterogeneity.
Keywords: clonal evolution; molecular alterations; single-cell; tumor behavior; tumor microenvironment.
Copyright © 2020 Senosain and Massion.
Figures



Similar articles
-
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.Cancer Discov. 2021 Jun;11(6):1490-1507. doi: 10.1158/2159-8290.CD-20-1274. Epub 2021 Feb 9. Cancer Discov. 2021. PMID: 33563664
-
Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.PLoS One. 2015 Sep 30;10(9):e0139264. doi: 10.1371/journal.pone.0139264. eCollection 2015. PLoS One. 2015. PMID: 26422230 Free PMC article.
-
Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.Clin Lung Cancer. 2013 Sep;14(5):521-6. doi: 10.1016/j.cllc.2013.04.005. Epub 2013 Jun 17. Clin Lung Cancer. 2013. PMID: 23786997
-
Tumor Heterogeneity in Pancreatic Adenocarcinoma.Pathobiology. 2018;85(1-2):64-71. doi: 10.1159/000477773. Epub 2017 Aug 5. Pathobiology. 2018. PMID: 28787741 Review.
-
Cellular heterogeneity and molecular evolution in cancer.Annu Rev Pathol. 2013 Jan 24;8:277-302. doi: 10.1146/annurev-pathol-020712-163923. Epub 2012 Oct 22. Annu Rev Pathol. 2013. PMID: 23092187 Review.
Cited by
-
Prognostic Significance of ANGPTL4 in Lung Adenocarcinoma: A Meta-Analysis Based on Integrated TCGA and GEO Databases.Evid Based Complement Alternat Med. 2022 Oct 7;2022:3444740. doi: 10.1155/2022/3444740. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jul 12;2023:9852450. doi: 10.1155/2023/9852450. PMID: 36248419 Free PMC article. Retracted.
-
Single-cell RNA sequencing reveals palmitoylation-driven cellular heterogeneity and prognostic biomarkers in lung adenocarcinoma.Transl Oncol. 2025 Aug 13;61:102501. doi: 10.1016/j.tranon.2025.102501. Online ahead of print. Transl Oncol. 2025. PMID: 40811979 Free PMC article.
-
Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures.Front Med (Lausanne). 2022 Mar 30;9:855387. doi: 10.3389/fmed.2022.855387. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35433762 Free PMC article.
-
Targeting HER3 to overcome EGFR TKI resistance in NSCLC.Front Immunol. 2024 Jan 4;14:1332057. doi: 10.3389/fimmu.2023.1332057. eCollection 2023. Front Immunol. 2024. PMID: 38239350 Free PMC article. Review.
-
Identification of Novel Subtypes in Lung Adenocarcinoma: Evidence from Gene Set Variation Analysis in Tumor and Adjacent Nontumor Samples.Dis Markers. 2022 Jan 19;2022:2602812. doi: 10.1155/2022/2602812. eCollection 2022. Dis Markers. 2022. PMID: 35096200 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources